Abstract |
Although pentoxifylline (PTXF), a phosphodiesterase inhibitor, has been reported to exert beneficial effects in cardiac bypass surgery, its effect and mechanisms against ischemia-reperfusion (I/R) injury in heart are poorly understood. Because I/R is known to increase the level of tumor necrosis factor ( TNF)-alpha in myocardium and PTXF has been shown to depress the production of TNF-alpha in failing heart, this study examined the hypothesis that PTXF may attenuate cardiac dysfunction and reduce TNF-alpha content in I/R heart. For this purpose, isolated rat hearts were subjected to global ischemia for 30 min followed by reperfusion for 2-30 min. Although cardiac dysfunction due to ischemia was not affected, the recovery of heart function upon reperfusion was markedly improved by PTXF treatment. This cardioprotective effect of PTXF was dose dependent; maximal effect was seen at a concentration of 125 microM. TNF-alpha, nuclear factor-kappaB ( NF-kappaB), and phosphorylated NF-kappaB contents were decreased in ischemic heart but were markedly increased within 2 min of starting reperfusion. The ratio of cytosolic-to-homogenate NF-kappaB was decreased, whereas the ratio of particulate-to-homogenate NF-kappaB was increased in I/R hearts. These changes in TNF-alpha and NF-kappaB protein contents as well as in NF-kappaB redistribution due to I/R were significantly attenuated by PTXF treatment. The results of this study indicate that the cardioprotective effects of PTXF against I/R injury may be due to reductions in the activation of NF-kappaB and the production of TNF-alpha content.
|
Authors | Ming Zhang, Yan-Jun Xu, Harjot K Saini, Belma Turan, Peter P Liu, Naranjan S Dhalla |
Journal | American journal of physiology. Heart and circulatory physiology
(Am J Physiol Heart Circ Physiol)
Vol. 289
Issue 2
Pg. H832-9
(Aug 2005)
ISSN: 0363-6135 [Print] United States |
PMID | 15833806
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cardiotonic Agents
- NF-kappa B
- Phosphodiesterase Inhibitors
- Tumor Necrosis Factor-alpha
- Pentoxifylline
|
Topics |
- Animals
- Cardiotonic Agents
(pharmacology)
- Heart
(drug effects, physiopathology)
- In Vitro Techniques
- Myocardial Reperfusion Injury
(metabolism, physiopathology)
- Myocardium
(metabolism)
- NF-kappa B
(metabolism)
- Pentoxifylline
(pharmacology)
- Phosphodiesterase Inhibitors
(pharmacology)
- Rats
- Tissue Distribution
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors)
|